Upload
muriel-nash
View
218
Download
1
Embed Size (px)
Citation preview
Jason Chiang, MD, PhD & Clayton Wiley, MD, PhDUniversity of Pittsburgh Medical CenterDepartment of Pathology Division of Neuropathology
• 67 years old male with multiple sclerosis (MS) for 39 years• Treated with Tysabri (Natalizumab) during the past 5 years
• What is MS?
• What is Tysabri?
Case History
2
• New onset of arm dysmetria, slurred speech and choking• Describe MRI findings
Case History
3
Radiologic Findings - MRI T1 + Contrast
R R
4
Radiologic Findings - MRI FLAIR/T2
R R
5
• CSF analysis:– Normal differential count and glucose level– Elevated protein level, elevated IgG index and oligoclonal bands
• Tysabri discontinued, plasmapheresis, IV dexamethasone
• Why are they stopping the Tysabri?
• Died 25 days after MRI
Further Studies and Clinical Course
6
Gross Neuropathology Findings
RR
7
8
Peri-ventricular Area Cerebellum
2x
20x
Microscopic Findings
H&E
Microscopic Findings
LFB/CV
Peri-ventricular Area Cerebellum
2x
20x
9
Neurofilament stain
10
Peri-ventricular Area Cerebellum
20x
Further Studies
Peri-ventricular Area
CD68
CD3
Cerebellum
10x
11
CD8
CD4CD68
CD3
JC Virus in situ Hybridization
12
4x 40x
Cerebellum
Timeline
13
Death10/5/2012
MRI6/5/2012
MRI9/10/2012
PML
Symptoms
TysabriTysabriTysabriTysabriTysabri PlasmapheresesSteroid
IRIS
MS
MS39 years
• Progressive multifocal leukoencephalopathy (PML)– Bilateral cerebellar white matter– Dentate nuclei– Middle cerebellar peduncles
• Superimposed immune reconstitution inflammatory syndrome (IRIS)
• Quiescent multiple sclerosis (MS) plaques– Multiple areas of cerebral peri-ventricular white matter– Gray and white matter of spinal cord
Final Diagnosis
14